Harvey RD, Rubinstein WS, Ison G, et al. Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis. ASCO Annual Meeting 2019, abstract LBA108.
Fase I/II-studie naar pembrolizumab en gelijktijdige chemoradiotherapie bij limited-stage SCLC
okt 2020 | Immuuntherapie, Longoncologie